JGUA
MRNA icon

John G. Ullman & Associates’s Moderna MRNA Stock Holding History

John G. Ullman & Associates’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$993K Sell
19,550
-1,600
-8% -$74.6K 0.13% 101
2025
Q4 		$624K Sell
21,150
-2,600
-11% -$70.6K 0.08% 120
2025
Q3 		$613K Buy
23,750
+7,650
+48% +$213K 0.08% 118
2025
Q2 		$444K Buy
16,100
+1,150
+8% +$30.3K 0.07% 127
2025
Q1 		$424K Buy
14,950
+4,650
+45% +$165K 0.07% 135
2024
Q4 		$428K Sell
10,300
-39,350
-79% -$1.88M 0.06% 134
2024
Q3 		$3.32M Buy
49,650
+38,400
+341% +$3.53M 0.48% 69
2024
Q2 		$1.34M Sell
11,250
-150
-1% -$19K 0.2% 94
2024
Q1 		$1.21M Buy
11,400
+7,750
+212% +$781K 0.19% 91
2023
Q4 		$363K Sell
3,650
-37,949
-91% -$3.19M 0.06% 135
2023
Q3 		$4.3M Buy
41,599
+13,200
+46% +$1.47M 0.7% 43
2023
Q2 		$3.45M Buy
+28,399
New +$3.79M 0.53% 54

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return